Biohaven Ltd (NYSE:BHVN)
$ 38.72 -0.6 (-1.53%) Market Cap: 3.42 Bil Enterprise Value: 3.22 Bil PE Ratio: 0 PB Ratio: 10.67 GF Score: 21/100

Q4 2020 Biohaven Pharmaceutical Holding Company Ltd Earnings Call Transcript

Mar 01, 2021 / 01:30PM GMT
Operator

Good morning. Welcome to Biohaven Pharmaceuticals Fourth Quarter 2020 and Full Year Results Call. (Operator Instructions) Please be advised that today's conference call may be recorded.

I would now like to turn -- hand the conference over to Biohaven's Chief Operating Officer, Clifford Bechtold. Thank you, and you may now begin.

Clifford Bechtold
Biohaven Pharmaceutical Holding Company Ltd. - President & GM of Biohaven Ireland and Chief Compliance Officer

Good morning, and thank you, and welcome to the Biohaven's Fourth Quarter 2020 Earnings Call.

Speaking on today's call are Dr. Vlad Coric, our Chief Executive Officer; Jim Engelhart, Chief Financial Officer; BJ Jones, Chief Commercial Officer; and Dr. Elyse Stock, our Chief Medical Officer.

Earlier this morning, we issued a press release announcing the fourth quarter 2020 highlights and a summary of our year-end results. A copy of this press release can be found on our website at biohavenpharma.com and will be on file with the 10-Q later filed today.

Before we begin,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot